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Abstract
Background: The prevalence of Helicobacter pylori including strains with putatively virulent genotypes is high, whereas the
H. pylori-associated disease burden is low, in Africa compared to developed countries. In this study, we investigated the
prevalence of virulence-related H. pylori genotypes and their association with gastroduodenal diseases in The Gambia.
Methods and Findings: DNA extracted from biopsies and H. pylori cultures from 169 subjects with abdominal pain,
dyspepsia or other gastroduodenal diseases were tested by PCR for H. pylori. The H. pylori positive samples were further
tested for the cagA oncogene and vacA toxin gene. One hundred and twenty one subjects (71.6%) were H. pylori positive.
The cagA gene and more toxigenic s1 and m1 alleles of the vacA gene were found in 61.2%, 76.9% and 45.5% respectively of
Gambian patients harbouring H. pylori. There was a high prevalence of cagA positive strains in patients with overt gastric
diseases than those with non-ulcerative dyspepsia (NUD) (p = 0.05); however, mixed infection by cagA positive and cagA
negative strains was more common in patients with NUD compared to patients with gastric disease (24.5% versus 0%;
p = 0.002).
Conclusion: This study shows that the prevalence of H. pylori is high in dyspeptic patients in The Gambia and that many
strains are of the putatively more virulent cagA+, vacAs1 and vacAm1 genotypes. This study has also shown significantly
lower disease burden in Gambians infected with a mixture of cag-positive and cag-negative strains, relative to those
containing only cag-positive or only cag-negative strains, which suggests that harbouring both cag-positive and cag-
negative strains is protective.
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Introduction
Helicobacter pylori is a genetically diverse microaerophilic gram
negative bacterial species that chronically infects the human
gastric mucosa, often starting in infancy and lasting for life [1].
About 50% of the world’s adult population is colonized, with
prevalences of over 80% in many developing countries including
The Gambia [2–4]. Earlier reports indicated high prevalence of H.
pylori colonization, but a low frequency of H. pylori-associated
disease in Africa [2,5,6], a phenomenon that was called the
‘‘African enigma’’ [2]. DNA sequencing of housekeeping and
virulence genes has shown that different sets of genotypes
predominate in different human populations [7]. Of particular
interests have been H. pylori’s cagA oncogene and toxigenic s1 and
m1 alleles of its vacA gene, which have been implicated in
gastroduodenal diseases caused by this pathogen both in
epidemiologic [8,9], experimental animal and cell culture infection
[10] studies. This said, several studies from different world regions
have not detected such an association [8,11,12], an outcome
suggesting the possibility of other virulence-modulating factors.
Individuals can be colonized by either a single or multiple
strains of H. pylori, and even colonization by what is initially a
single strain can, over time, lead to the emergence of multiple H.
pylori subpopulations, due variously to mutation or to genetic
recombination either between duplicate sequences in the single
strain’s genome or with DNAs from other transiently colonizing
strains [8]. The prevalence of such mixed infections has been
reported to vary (5–68%) [13–17] depending on geographical
region, whether in a developed or developing country (low and
high overall infection risk, respectively), and probably also
methods of analysis. The H. pylori virulence-associated vacuolating
cytotoxin (vacA) and cag pathogenicity island (cag PAI) genes, and
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also the cag empty site in strains lacking the cag PAI, are typically
found in only one copy per genome [17–20]. Accordingly,
detection of both the cagA gene and the cag empty site, or of
both s1 and s2 (signal sequence; at 59 end of gene) or both m1 and
m2 (middle region) alleles of vacA in a biopsy or in pool of H. pylori
from a person indicates mixed infection.
We wondered if having mixed infection might influence the risk
of gastric disease; for example, if strains of different genotypes
might occupy a broader range of niches in the stomach as has been
seen during experimental infection [21] and thereby impact on
clinical outcome. In this study, we investigated the genotypes of H.
pylori in The Gambia and the relation of apparently single versus
mixed infections to gastroduodenal diseases.
Materials and Methods
Ethics statement
Ethical approval of this study was obtained from the joint
Medical Research Council (MRC) Unit, The Gambia/Gambia
Government Ethics Committee and Division of Microbiology
Infectious Diseases (DMID) International Review Board.
Patients
Clinical data from the MRC Unit in The Gambia revealed that
of 428 patients with gastric complaints investigated by gastric
endoscopy between 2003–2008, 8 (1.9%) had gastric carcinoma,
20 (4.7%) and 15 (3.5%) had gastric and duodenal ulcers
respectively, and that the others (89.9%) did not have such overt
disease (diagnosed as non-ulcer dyspepsia; NUD (data not shown).
All patients referred for endoscopy to the MRC Unit during the
years 2003 to 2008 were initially considered eligible for inclusion:
All 169 subjects who agreed to join this study provided written
informed consent; in addition, for children less than 18 years,
antral biopsies were obtained only after informed written parental
consent. Patients with severe oesophago-gastroduodenal disease,
including those with gastro-oesophageal varices, a small number
with advanced gastric cancer and those on H. pylori eradication
therapy, were excluded from the study. One hundred and twenty
one patients from whose biopsies we successfully amplified
virulence genes were analysed here. The mean age of these
subjects was 35, ranging from 9 to 80 years. All the subjects were
Gambians and most of them (75) came from the Greater Banjul
Area, 38 from the West Coast region, 5 from Lower River region
and 3 from North Bank region of The Gambia.
Gastroscopy results
Endoscopic examination showed that of the 121 study subjects,
11 had gastric ulcer, 7 had duodenal ulcer, 1 had both gastric and
duodenal ulcers, 7 had gastric erosions, 1 had gastric carcinoma
and all other subjects (94) who presented with either abdominal
pain or dyspepsia had no evidence or history of gastric or duodenal
ulcers.
The biopsies collected from patients were stored in Brain Heart
Infusion (BHI) broth containing 20% glycerol and transported on
ice to the laboratory for processing or stored at 270uC until used.
Our previous data demonstrated that in The Gambia detection of
mixed H. pylori strains in individual biopsies was best undertaken
by PCR amplification directly from biopsy material rather than by
bacterial culture [22].
Genomic DNA extraction directly from biopsies
Total genomic DNA was extracted directly from the biopsy
material by using a combination of bead-beater and the QIAamp
DNA isolation kit (Qiagen, UK) as previously described [22].
PCR amplification
PCR was performed to detect the cagA gene and cag empty site,
and the signal sequence (s1 and s2) and middle region (m1 and m2)
alleles of the vacA gene, as previously described [23] using the
primers listed in table 1 and the following cycling conditions: 30
cycles of 94uC for 1 min, 55uC or 60uC for 1 min and 72uC for
1 min. The amplified genes were detected by electrophoresis in a
1.5% gel with ethidium bromide (500 ng/ml) and bands were
visualized using Gel Doc 2000 (Bio-Rad laboratories, Milan, Italy).
The presence of a particular gene or allele was inferred when a
product of the expected size (table 1) was obtained using
appropriate primers.
Statistical analysis
We assessed the prevalences of infection with single vs. multiple
strains. For the cagA gene, for example, we noted the occurrence of
cagA positive, cag empty site and mixed (cagA positive and cag PAI
negative) infections. Prevalences were compared between disease
groups and p-values were determined using Fisher’s exact test.
Table 1. Primers used in this study.
Region Primer Nucleotide sequence bp reference
cagA cagA-F
cagA-R
gat aac agg caa gct ttt gag g
ctg caa aag att gtt tgg cag a
349 [23]
cag empty
site
Luni-1
R5280
aca ttt tgg cta aat aaa cgc tg
ggt tgc acg cat ttt ccc tta atc
535 [23]
vacAs1 &
vacAs2
Va1-F
Va1-R
atg gaa ata caa caa ac¸a cac
ctg ctt gaa tgc gcc aaa c
s1 259
s2 289
[23]
vacAm1 Va3-F
Va3-R
ggt caa aat gcg gtc atg g
cca ttg gta cct gta gaa ac
290 [23]
vacAm2 Va4-F
Va4-R
gga gcc cca gga aac att g
cat aac tag cgc ctt gca c
352 [23]
doi:10.1371/journal.pone.0027954.t001
Table 2. Prevalence of Helicobacter pylori genotypes.
H. pylori genotypes n %
cagA+ 74 61.2
cagA2 21 17.4
cagA+ & cagA2 23 19.0
No amplification of cagA or cag emptysite 3 2.5
s1 93 76.9
s2 23 19.0
s1 & s2 1 0.8
no amplification of s1 or s2 4 3.3
m1 55 45.5
m2 36 29.8
m1 & m2 22 18.2
No amplification of m1 or m2 8 6.6
doi:10.1371/journal.pone.0027954.t002
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Results
Prevalence of H. pylori genotypes
One hundred and twenty one patients of the 169 study
participants were inferred to be infected with H. pylori when DNAs
extracted from their biopsies were tested by PCR for the presence
of H. pylori cagA gene and cag empty site. Seventy four biopsies
(61.2%) were positive for the cagA gene only, 21 (17.4%) were
positive for the cag empty site only and 23 (19%) were positive for
both. In parallel we also tested for the vacA gene presence and
allele types. In all, 93 of 121 (76.9%) were positive only for the
vacAs1 allele, 23 (19.0%) were positive only for the vacAs2 allele and
1 (0.8%) was positive for both. Only m1 or only m2 alleles of vacA
were detected in 55 (45.5%) and 36 (29.8%) of biopsies tested
respectively; both m1 and m2 (mixed infections) were found in 22
(18.2%) biopsies and up to 6.6% of biopsy DNAs failed to amplify
for individual alleles (table 2).
Association between H. pylori genotypes
Of the 93 H. pylori strains that were positive only for vacAs1, 72
(77.4%) were cagA positive compared with only 1 (4.3%) cagA
positive among the 23 strains that were positive only for vacAs2;
most (16) of them contained the cag empty site allele only (table 3).
Similarly, nearly all s1m1 positive biopsies (92.5%) contained cagA
genes, whereas none of those containing only vacA s2m2 allele were
cagA positive (table 3).
Association of H. pylori virulence genes with upper
gastric diseases
cagA positive H. pylori strains were found more frequently among
study participants with gastroduodenal diseases than those with
NUD: duodenal ulcers (6/7; 85.7%), gastric erosions (5/7, 71.4%),
gastric ulcers (8/11, 72.7%); no overt gastric disease (53/94,
56.4%) (table 4). In the 27 patients with overt gastric disease,
77.8% were cagA positive compared to 56.4% of those with NUD
(p-value = 0.05, table 5). Toxigenic s1m1 alleles were found in 6 of
the 11 (54.5%) patients diagnosed with gastric ulcer, 42.9%,
42.9% and 42.6% in those with duodenal ulcers, gastric erosions
and NUD, respectively (table 6). The prevalence of vacA alleles
were similar in the two groups of patients; overt disease vs. NUD.
That is, no association was found between vacA alleles and clinical
outcome (p = 0.94, table 7).
All 27 subjects with overt gastric diseases were of uniform cagA
status (that is, uniquely cagA gene positive or cag empty site
positive), whereas only 72.3% (68/94) of NUD were of uniform
status; the other 23 contained mixed (cagA positive, cag empty site
positive) infections. Three other biopsy samples did not give cagA
gene or cag empty site amplification (table 5). This association
between uniform cagA status and overt disease was statistically
significant (p = 0.002).
In terms of age distribution, no association was found between
age and overt gastric disease (24.5%,30 years, 12.5% 30–40 years
and 27.8%.40 years; p-value = 0.26, table 8), or frequency of
Table 3. Association of vacA with cagA Helicobacter pylori genotypes.
cagA+ cagA2 cagA+ & cagA2 Incomplete cagA
H. pylori genotypes n (%) n (%) n (%) n (%) Total
s1m1 49 (92.5) 1 (1.9) 3 (5.7) 0 (0) 53
s1m2 9 (50) 3 (16.7) 5 (27.8) 1 (5.6) 18
s2m2 0 (0) 16 (88.9) 2 (11.1) 0 (0) 18
s2m1 0 (0) 0 (0) 0 (0) 0 (0) 0
s1m1m2 12 (66.7) 0 (0) 6 (33.3) 0 (0) 18
s1s2m1m2 0 (0) 0 (0) 1 (100) 0 (0) 1
s2m1m2 0 (0) 0 (0) 3 (100) 0 (0) 3
Incomplete VacA 4 (40) 1 (10) 3 (30) 2 (20) 10
Incomplete cagA= cagA and cag empty site were not detected.
Incomplete vacA= either vacA s or vacA m regions were not detected (4/10 vacAs1 was detected & vacAm was missing, 2/10 vacAs2 detected and vacAm missing, 2/10
vacAm1 detected and vacAs missing and for 2/10 both vacAs and vacAm were missing).
doi:10.1371/journal.pone.0027954.t003
Table 4. Association between cagA genotypes and disease type.
DU GC GE GU GUDU NUD Total
cagA status n (%) n (%) n (%) n (%) n (%) n (%) n (%)
cagA+ 6 (85.7) 1 (100) 5 (71.4) 8 (72.7) 1 (100) 53 (56.4) 74 (61.2)
cagA2 1 (14.3) 0 (0) 2 (28.6) 3 (27.3) 0 (0) 15 (16.0) 21 (17.4)
cagA+& cagA2 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 23 (24.5) 23 (19.0)
No amplification 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (3.2) 3 (2.5)
Total 7 (5.8) 1 (0.8) 7 (5.8) 11 (9.1) 1 (0.8) 94 (77.7) 121 (100)
DU=duodenal ulcer, GC =gastric carcinoma, GE = gastric erosion, GU=gastric ulcer, GUDU=gastric ulcer and duodenal ulcer, NUD=Non-ulcerative disease.
doi:10.1371/journal.pone.0027954.t004
Effect of Mixed Infection of H. pylori on Disease
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mixed infection (15.1%,30 years, 18.8% 30–40 years, 25%.40
years; p-value = 0.46, table 9).
Discussion
H. pylori infection is common in dyspeptic adults in The Gambia
[4,22], as is typical of developing countries. The range of H. pylori
genotypes implicated in overt gastroduodenal disease as opposed
to benign colonization or possibly even beneficial carriage [9,24]
had not been extensively investigated in Sub–Saharan Africa.
Here we studied the distribution of H. pylori’s main virulence
genes, cagA and toxigenic alleles of vacA, in The Gambia, and their
possible associations with disease outcome.
The prevalence of gastroduodenal disease (10%) that we
detected endoscopically is similar to that reported elsewhere in
Sub-Saharan Africa [25] and may be lower than that in Europe
and North America. However, these estimated prevalences should
be interpreted with caution as they may not be representative of
the general population, but instead indicate the prevalence of
disease among people with gastric complaints of sufficient severity
to prompt diagnostic endoscopy. We found that just over half of
Gambian isolates (61.2%) carried the cagA gene (table 2) and that
mixed infections (both cagA positive and cag PAI negative) were
common. We also found toxigenic vacAs1 and m1 alleles to be
abundant, but not universal (76.9% and 45.5%). In contrast, most
H. pylori strains from Egypt carried vacAs2 and m2 alleles, (57.1%
and 85.7%, respectively) [9], whereas some 90% or more of strains
in Japan, coastal China, and India carried vacAs1 alleles [23,26–
28]. vacAm1 type alleles were also nearly universal in Japanese
main island strains, whereas vacAm2 strains were predominant in
coastal China [28,29]. In this study, most of the vacAs1 strains
(77.4%) were cagA positive similar to what was observed in a study
in South Africa [30]. Up to 6.6% of samples in this study failed to
amplify for individual genes consistent with other findings [22,30],
perhaps due to PCR inhibitors or potent nucleases in some gastric
biopsies as also suggested previously [22,30,31].
Thus, our data reinforce conclusions that different H. pylori
genotypes, especially types of genes or alleles implicated in virulent
vs. benign infections, predominate in different human populations.
Strains of the vacA s1m2 type were most common in coastal China,
and also seemed to predominate in Southern Nigeria [32]; and
both s1m2 and s2m2 allele types were abundant in South Africa
[30]. This contrasts with the predominance of vacA s1m1 strains
found in our Gambian study participants. This apparent difference
between Nigerian and Gambian strain genotypes could have
several explanations, including the distance separating these two
West African countries (.3000 km), or climatic differences (high
rainfall and humidity in Southern Nigeria vs aridity for much of
the year in The Gambia). Such explanations would entail genetic
divergence by random genetic drift and selection for adaptation to
local conditions respectively.
Table 5. cagA and clinical outcome.
Overt gastric disease NUD
cagA status n % n %
cagA+ 21 77.8 53 56.4
cagA2 6 22.2 15 16.0
cagA+ & cagA2 0 0 23 24.5
no amplification 0 0 3 3.2
Total 27 100 94 100
doi:10.1371/journal.pone.0027954.t005
Table 7. Association between vacA genotypes and clinical
outcome.
Overt gastric disease NUD
H. pylori genotypes n % n %
s1m1 13 48.1 40 42.5
s1m2 3 11.1 15 16.0
s2m2 5 18.5 13 13.8
s1m1m2 4 14.8 14 14.9
s1s2m1m2 0 0 1 1.1
s2m1m2 0 0 3 3.2
Incomplete vacA 2 7.4 8 8.5
Total 27 100 94 100
Incomplete vacA= either vacA s or vacA m regions were not detected (4/10
vacAs1 was detected & vacAm was missing, 2/10 vacAs2 detected and vacAm
missing, 2/10 vacAm1 detected and vacAs missing and for 2/10 both vacAs and
vacAm were missing).
doi:10.1371/journal.pone.0027954.t007
Table 8. Association between age and disease.
Overt disease NUD
Age groups n (%) n (%) Total
,30 years 13 (24.5) 40 (74.5) 53
30–40 years 4 (12.5) 28 (87.5) 32
.40years 10 (27.8) 26 (72.2) 36
p-value = 0.26.
doi:10.1371/journal.pone.0027954.t008
Table 6. Association between vacA genotypes and disease
type.
vacA
status DU* GC* GE* GU* GUDU* NUD* Total
n (%) n (%) n (%) n (%) n (%) n (%) n (%)
s1m1 3 (42.9) 1 (100) 3 (42.9) 6 (54.5) 0 (0) 40 (42.6) 53 (43.8)
s1m2 1 (14.3) 0 (0) 2 (28.6) 0 (0) 0 (0) 15 (16.0) 18 (14.9)
s2m2 0 (0) 0 (0) 2 (28.6) 3 (27.3) 0 (0) 13 (13.8) 18 (14.9)
s1m1m2 3 (42.9) 0 (0) 0 (0) 1 (9.1) 0 (0) 14 (14.9) 18 (14.9)
s1s2m1m2 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (1.1) 1 (0.8)
s2m1m2 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 3 (3.2) 3 (2.5)
1Incomplete
vacA
0 (0) 0 (0) 0 (0) 1 (9.1) 1 (100) 8 (8.5) 10 (8.3)
Total 7 1 7 11 1 94 121
*Du=Duodenal ulcer; GC = gastric cancer; GE = gastric erosion; GU=gastric
ulcer; GUDU=gastric and duodenal ulcers; NUD=non-ulcerative diseases.
1Incomplete vacA=either vacA s or vacA m regions were not detected (4/10
vacAs1 was detected & vacAm was missing, 2/10 vacAs2 detected and vacAm
missing, 2/10 vacAm1 detected and vacAs missing and for 2/10 both vacAs and
vacAm were missing).
doi:10.1371/journal.pone.0027954.t006
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Previous reports of a lower than expected prevalence of H. pylori
associated disease in Africa [2,5,6] might in principle reflect the
influence of bacterial and/or human genotypes, environment
including other infections (e.g. parasitic infections that affect host
response to H. pylori), normal gut flora, diet (including anti-
oxidants, salt, spices) or likelihood of seriously ill persons being
diagnosed and their cases entered in registries. In accord with this
last explanation, have been suggestions that gastroduodenal
disease is actually common in Africa, that there is no African
enigma [11,12]. The cagA gene and vacAs1 and m1 alleles are often
linked to severe disease, and the vacAs2 and m2 alleles with more
benign infections (gastritis only) in other populations. This is
partially reflected in our results: with respect to cagA we did not
find a ‘‘Gambian-H. pylori virulence gene’’ enigma; disease
associations with vacA were less clear cut. The possible effects of
bacterial or human genetic and physiologic differences, food,
history of other infections and other environmental and lifestyle
factors, on outcomes of chronic H. pylori infections in sub-Saharan
Africa merit further more detailed analyses.
Most important, was our finding that co-existence of cagA
positive and cagA negative strains was significantly more common
amongst patients with NUD than among those with overt disease,
which suggests that mixed colonization is protective. In principle,
protection against development of overt gastric disease might stem
from simple competition – whereby carriage of an avirulent (cagA-
negative) strain diminishes the vigour of growth of a coexisting
virulent strain, thereby reducing its impact on host tissues. It is also
possible that factors in cag-negative strains that diminish the impact
of virulence proteins such as CagA might predominate during
cagA-positive and cagA-negative mixed infections [33]. Or, more
generally, an increased complexity of immune responses during
chronic infection by multiple divergent H. pylori strains might
effectively diminish the inflammatory action of an individual
virulent strain, and thereby resultant pathology in host tissues, as
noted with other infections [34–37]. In accord with this idea, the
risk of developing overt disease seemed higher in subjects
apparently colonized only with cagA negative H. pylori, than in
those with mixed cagA positive and negative strains. Conversely,
however, the presence of mixed infections might also stem from
increased intrinsic host susceptibility to H. pylori infection and
equally the development of a more severe clinical outcome
[38,39].
This study has revealed frequent gastro-duodenal disease
among Gambians with gastric complaints. Many strains carried
cagA+ and s1, m1 alleles of vacA, which are disease associated in
many European and North American populations. Although cagA
status was associated with disease in The Gambia, alleles of vacA
were not. Comparison of our data with those from southern
Nigeria pointed to a potentially significant difference in linkage of
signal sequence (s1 vs. s2) and middle region (m1 vs. m2) alleles,
which control the potency and tissue specificity of toxin action
respectively (s1m1 most common in The Gambia, vs. s1m2 most
common in Nigeria). The possibility that such differences reflect
selection for optimal genotypes or random genetic drift in these
well-separated West African nations merit further study. We
suggest that our most interesting finding is the significantly lower
disease burden in Gambians infected with a mixture of cag-positive
and cag-negative strains, relative to those containing only cag-
positive or only cag-negative strains. The possibility that repeated
exposure would be beneficial in Sub-Saharan Africa and in
developing countries more generally needs to be considered when
developing more effective treatment strategies for treating H. pylori
infection and risks of gastroduodenal disease [40].
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